Search results for "Drug costs"


 
Results 1 - 10 of about 28 for "Drug costs".
Sort by: Relevance | Newest | Oldest

Factoring drug costs into diabetes decisions

A sizable number of patients with diabetes do not consistently fill their prescriptions or take less than the prescribed amount due to costs, but there are ways to make it easier on a patient's pocketbook.
https://acpinternist.org/archives/2022/05/factoring-drug-costs-into-diabetes-decisions.htm
1 May 2022

ACP recommends policies to curb prescription drug costs

Transparency in pricing, cost, and comparative value and elimination of restrictions on using quality-adjusted life-years in comparative effectiveness research are 2 of the recommendations.
https://acpinternist.org/weekly/archives/2016/03/29/2.htm
29 Mar 2016

Research looks at out-of-pocket prescription costs

One study evaluated the effect of real-time pop-up recommendations for lower-priced prescription alternatives, while a second study modeled capping monthly expenses and shifting the patients' savings back to the insurance plan.
https://acpinternist.org/weekly/archives/2022/09/20/2.htm
20 Sep 2022

Looking at LARCs in primary care

This issue includes stories on long-acting reversible contraceptives, medications for type 2 diabetes, and issues affecting the elderly.
https://acpinternist.org/archives/2022/05/editors-note.htm
1 May 2022

ACP's prescription for rising drug costs

ACP has 4 concrete proposals to address rising prescription drug prices: regulating and negotiating prices, enhancing transparency, increasing competition, and considering value.
https://acpinternist.org/archives/2016/05/washington.htm
1 May 2016

ACP calls for increased competition in prescription drug market

The new policy paper is the third installment of a series. Previous papers have offered recommendations related to public health programs and pharmacy benefit managers.
https://acpinternist.org/weekly/archives/2020/09/15/6.htm
15 Sep 2020

ACP issues policy recommendations to cut rising costs of prescription drugs

ACP called for increased transparency, lower out-of-pocket costs for patients, and improved access to affordable medications.
https://acpinternist.org/weekly/archives/2019/11/12/1.htm
12 Nov 2019

Latest updates on ACP's priorities, initiatives

ACP Spotlight offers readers a look at ACP's current top priorities and initiatives, as well as highlights from our e-newsletter, ACP Internist Weekly.
https://acpinternist.org/archives/2020/01/latest-updates-on-acps-priorities-initiatives.htm
1 Jan 2020

8 ways that members can guide College activities

ACP's members can meet the challenges of today's world by becoming more involved in their local chapters, serving on national committees, or running for leadership positions within the national organization.
https://acpinternist.org/archives/2017/03/presidents.htm
1 Mar 2017

Sacubitril-valsartan appears cost-effective in certain heart failure patients

Treatment value was highest in patients with class II heart failure, who also benefited most from treatment in the PARADIGM-HF trial, and improved outcomes with the drug would need to be sustained for at least 36 months to keep the cost per quality-adjusted life-year below a $100,000 threshold.
https://acpinternist.org/weekly/archives/2016/08/30/2.htm
30 Aug 2016

Result Page: Prev   1   2   3   Next